New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
10:12 EDTNVGNNovogen Limited halted for volatility after jumping 83% to $4.24
News For NVGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 15, 2015
11:14 EDTNVGNNovogen announces key finding in regenerative medicine program
Novogen Limited announced earlier, an important discovery in its regenerative medicine program that has delivered a key proof-of-concept step forward in the quest to develop drugs capable of stimulating the function of brain tissue stem cells. In April, Novogen established a partnership with Genea Biocells, an Australian company with world-leading expertise in the production, growth and development of human embryonic stem cells. The original purpose of that collaboration was to mine the company's super-benzopyran drug technology platform for new therapies with the capacity to repair aberrant stem cells in people with various neurodegenerative and musculedegenerative disorders such as muscular dystrophies and motor neurone diseases. That program recently was extended to look at the ability of that same drug platform to stimulate the growth of healthy brain stem cells to create new nerve cells. That has been achieved in what is the first key step in the path to the development of a new family of drugs to treat brain injury. Shares of Novogen are higher by 29% or 61c to $2.70 in late morning trading.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use